Silent Ischemia in People With Diabetes: A Condition That Must Be Heard
Open Access
- 1 January 2003
- journal article
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 21 (1) , 5-9
- https://doi.org/10.2337/diaclin.21.1.5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2003
- Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study)The American Journal of Cardiology, 2002
- Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- High-Sensitivity C-Reactive ProteinCirculation, 2001
- Consensus Development Conference on the Diagnosis of Coronary Heart Disease in People With Diabetes: 10–11 February 1998, Miami, FloridaDiabetes Care, 1998